Generic and biosimilar drug producer Sandoz has agreed a $265 million settlement that aims to put allegations of price-fixing brought in a Pennsylvania lawsuit behind it. The agreement – which ...
After months of deliberation, and no formal offers from a buyer, Novartis has decided that its generics business Sandoz will be spun out into an independent company. The Swiss pharma group said ...
RBC Sandoz Group AG Sponsored ADR (SDZNY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy). Sandoz Group AG ...
(RTTNews) - Swiss generic pharmaceutical company Sandoz Group AG (SDZNY) announced on Monday that Peter Stenico has been appointed as the new President Region International and member of the ...
The Gadgets 360 Best Tablets page shows the top-rated tablets reviewed by us in the recent past. The tablets were launched less than 2 years ago, and have received a rating of 8 or above. When you ...
About half of people do not initially respond to treatment. To prevent relapse, people who take medication for depression should continue with treatment — even after symptoms improve or go away ...
because the longer depression goes untreated, the harder it is to treat. Medication is often prescribed for children with depression, but its effectiveness is very much a matter of debate ...
It released its first Android smartphone in 2009, and can be credited with the launch of the first Android tablet back in 2010. The company is among the biggest players in the smartphone market in the ...
A new study revealed that these programs may ... Study Finds New Link Between Food Choices, Depression and Alzheimer's Disease Feb. 5, 2025 — New research has shown that diet could influence the ...
For those worried about breaking their backs carrying their laptops to every business trip they embark on, a tablet may be their best option. Tablets are just as powerful as regular laptops in ...
Johnson & Johnson (J&J) has announced it will acquire Intra-Cellular Therapies, a company specialising in central nervous system disorder treatments. The news was first reported by Bloomberg late ...